Ropo Injection 10000 IU is an erythropoiesis‑stimulating agent (ESA) containing recombinant human erythropoietin alfa, a hormone that helps the bone marrow produce red blood cells. It is commonly used to treat anemia (low hemoglobin) caused by chronic kidney disease (CKD), cancer chemotherapy, HIV treatment with zidovudine, or other conditions where the body’s natural erythropoietin is insufficient. This injectable therapy helps reduce fatigue and weakness associated with anemia and may decrease the need for blood transfusions under medical supervision.

Price in Pakistan

The approximate price of Ropo Injection 10000 IU in Pakistan is around Rs. 3,100 – Rs. 3,450 per pre‑filled syringe, varying by pharmacy and location.

Uses

• Treats anemia due to chronic kidney disease (especially in patients on dialysis)

• Manages anemia caused by cancer chemotherapy

• Helps anemia associated with HIV treatment and low red blood cell counts

• Reduces the need for blood transfusions in surgical or high‑risk patients

Benefits

• Stimulates red blood cell production to correct anemia

• Helps improve energy, strength, and well‑being

• Reduces symptoms like fatigue and shortness of breath

• May decrease dependency on blood transfusions in chronic conditions

• Suitable for adult and pediatric use (under medical guidance)

Prescription Required: Yes

Generic Name: Erythropoietin Alfa

Use: Treatment of anemia due to CKD, chemotherapy, dialysis & related causes

How It Works

Ropo Injection contains recombinant human erythropoietin alfa, a synthetic form of the natural hormone erythropoietin. It stimulates the bone marrow to increase the production of red blood cells (erythrocytes), improving the oxygen‑carrying capacity of the blood and helping alleviate symptoms of anemia such as tiredness, weakness, and shortness of breath.

Dosage & Administration

• Administered only by a doctor or nurse via intravenous (IV) or subcutaneous (SC) injection

• Dose and frequency depend on body weight, hemoglobin levels, and clinical condition

• Regular monitoring of hemoglobin and blood pressure is essential during treatment

• Do not self‑administer the injection; follow healthcare provider instructions precisely

Common Side Effects

• High blood pressure (hypertension)

• Headache and dizziness

• Joint or muscle pain

• Nausea, vomiting, fever, or rash

• Injection site irritation or swelling

Drug Interactions & Precautions

• Inform your doctor about all other medications being taken

• Monitor blood pressure closely — Ropo can raise blood pressure in some patients

• Use caution in patients with heart disease or stroke history

• Not to be used in uncontrolled hypertension or known allergy to erythropoietin

Do Not Use If

• Known allergy to erythropoietin or injection components

• Uncontrolled high blood pressure

• Pure red cell aplasia (bone marrow disorder) without specialist evaluation

Storage

Store in a refrigerator (2 – 8 °C) and do not freeze. Protect from light and keep out of reach of children. Allow the injection to reach room temperature before administration if instructed.

FAQs

Q1: What is Ropo Injection 10000 IU used for?

It’s used to treat anemia from chronic kidney disease, chemotherapy, and other causes where red blood cell production is low.

Q2: Is a prescription required?

Yes, Ropo Injection must be prescribed and administered by a healthcare provider.

Q3: How is it given?

By IV or subcutaneous injection in a clinic or hospital setting.

Q4: Does it improve energy?

Yes, by increasing red blood cells and oxygen delivery, it reduces fatigue and weakness.

Q5: Are there side effects?

Side effects can include high blood pressure, headache, nausea, and site irritation.

Q6: How often should levels be checked?

Your doctor will monitor hemoglobin and blood pressure regularly during treatment.

Q7: Can children use it?

Yes, it may be used in children for anemia under careful medical supervision.

Q8: Does it reduce the need for blood transfusions?

In some cases, yes — by stimulating red blood cell production, it can reduce transfusion requirements.